Publikationen von Marcus Ising

Ising, M.; Dietl, T.; Dirlich, G.; Vogl, L.; Pollmächer, T.; Nickel, T.; Sonntag, A.; Strian, F.; Lechner, C.; Lauer, C. J. et al.; Modell, S.: Long-latency somatosensory potentials in high risk probands for affective disorders. Journal of Psychiatric Research 38 (2), S. 219 - 221 (2004)

Binder, E. B.; Salyakina, D.; Lichtner, P.; Wochnik, G. M.; Ising, M.; Pütz, B.; Papiol, S.; Seaman, S.; Lucae, S.; Kohli, M. et al.; Nickel, T.; Künzel, H.; Fuchs, B.; Majer, M.; Pfennig, A.; Kern, N.; Brunner, J.; Modell, S.; Baghai, T.; Deiml, T.; Zill, P.; Bondy, B.; Rupprecht, R.; Messer, T.; Köhnlein, O.; Dabitz, H.; Brückl, T.; Müller, N.; Pfister, H.; Lieb, R.; Mueller, J. C.; Löhmussaar, E.; Strom, T. M.; Bettecken, T.; Meitinger, T.; Uhr, M.; Rein, T.; Holsboer, F.; Müller-Myhsok, B.: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 36, S. 1319 - 1325 (2004)

Ising, M.; Lauer, C. J.; Holsboer, F.; Modell, S.: The Munich vulnerability study on affective disorders: premorbid psychometric profile of affected individuals. Acta Psychiatrica Scandinavica 109, S. 332 - 338 (2004)

Majer, M.; Ising, M.; Künzel, H.; Binder, E. B.; Holsboer, F.; Modell, S.; Zihl, J.: Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders. Psychological Medicine 34, S. 1453 - 1463 (2004)

Wetter, T. C.; Ising, M.: Association between polymorphism within the promoter region of the serotonin transporter gene and treatment response in depression - further evidence but still controversial issues. Sleep Medicine 5 (1), S. 93 - 95 (2004)

Künzel, H. E.; Binder, E. B.; Nickel, T.; Ising, M.; Fuchs, B.; Majer, M.; Pfennig, A.; Ernst, G.; Kern, N.; Schmid, D. A. et al.; Uhr, M.; Holsboer, F.; Modell, S.: Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 28 (12), S. 2169 - 2178 (2003)

Künzel, H. E.; Zobel, A. W.; Nickel, T.; Ackl, N.; Uhr, M.; Sonntag, A.; Ising, M.; Holsboer, F.: Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects. Journal of Psychiatric Research 37 (6), S. 525 - 533 (2003)

Ackl, N.; Schreiber, Y. A.; Ising, M.; Sonntag, A.; Auer, D. P.: Evaluation of H-1-MRS as diagnostic marker for mild cognitive impairment and dementia. Pharmacopsychiatry 36 (5), S. 210 - 210 (2003)

Adena, S. M.; Ising, M.; Lauer, C.; Holsboer, F.; Modell, S.: The effects of RS-86 on sleep with respect to depression and HLA-type. Pharmacopsychiatry 36 (5), S. 210 - 210 (2003)

Brunner, J.; Ising, M.; Binder, E. B.; Künzel, H. E.; Nickel, T.; Pfennig, A.; Kern, N.; Fuchs, B.; Majer, M.; Holsboer, F. et al.; Modell, S.: Prediction of response to antidepressant monotherapy. Pharmacopsychiatry 36 (5), S. 216 - 216 (2003)

Bschor, T.; Ising, M.; Bauer, M.; Lewitzka, U.; Skerstupeit, M.; Müller-Oerlinghausen, B.; Baethge, C.: Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects. Pharmacopsychiatry 36 (5), S. 216 - 216 (2003)

Ising, M.; Adena, S. M.; Pfennig, A.; Binder, E. B.; Kern, N.; Huber, J.; Modell, S.; Holsboer, F.: Munich Vulnerability Study - Familial vulnerability for affective disorders: Search for endophenotypes. Pharmacopsychiatry 36 (5), S. 237 - 237 (2003)

Ising, M.; Binder, E.; Brunner, J.; Fuchs, B.; Kern, N.; Künzel, H. E.; Majer, M.; Nickel, T.; Pfennig, A.; Modell, S. et al.; Holsboer, F.: Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders. Pharmacopsychiatry 36 (5), S. 237 - 237 (2003)

Kern, N.; Binder, E. B.; Künzel, H. E.; Pfennig, A.; Fuchs, B.; Ising, M.; Erhardt, A.; Lucae, S.; Müller-Myhsok, B.; Modell, S. et al.; Keck, M. E.; Holsboer, F.: Is there a genetic continuum between anxiety and depression? Pharmacopsychiatry 36 (5), S. 239 - 239 (2003)

Pfennig, A.; Kuenzel, H. E.; Kern, N.; Fuchs, B.; Brunner, J.; Ising, M.; Modell, S.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.: HPA axis dysregulation and suicidal behavior in depression - Differentiation of a genetically distinct subgroup? Pharmacopsychiatry 36 (5), S. 252 - 253 (2003)

Schüssler, P.; Uhr, M.; Weikel, J. C.; Schmid, D. A.; Held, K.; Mathias, S.; Ising, M.; Steiger, A.: Nocturnal ghrelin levels in normal controls - effects of gender. Pharmacopsychiatry 36 (5), S. 264 - 264 (2003)

Weikel, J. C.; Held, K.; Wichniak, A.; Ising, M.; Schmid, D. A.; Mathias, S.; Uhr, M.; Steiger, A.: Ghrelin promotes slow-wave sleep in man. Pharmacopsychiatry 36 (5), S. 271 - 272 (2003)

Wichniak, A.; Brunner, H.; Ising, M.; Gil, F. P.; Holsboer, F.; Friess, E.: Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression. Pharmacopsychiatry 36 (5), S. 272 - 272 (2003)

Steiger, A.; Weikel, J. C.; Wichniak, A.; Ising, M.; Brunner, H.; Friess, E.; Held, K.; Mathias, S.; Schmid, D. A.; Uhr, M.: Ghrelin promotes slow-wave sleep in man. Biological Psychiatry 53 (8 Suppl.), S. 209S - 209S (2003)

Nickel, T.; Sonntag, A.; Schill, J.; Zobel, A. W.; Ackl, N.; Brunnauer, A.; Murck, H.; Ising, M.; Yassouridis, A.; Steiger, A. et al.; Zihl, J.; Holsboer, F.: Clinical and neurobiological effects of tianeptine and paroxetine in major depression. Journal of Clinical Psychopharmacology 23 (2), S. 155 - 168 (2003)